Touboul P, Atallah G, Kirkorian G
Arch Mal Coeur Vaiss. 1981 Nov;74(11):1333-40.
The electrophysiological effects of lorcainide (R 15 899) were studied in 15 patients. Atrioventricular conduction was analysed by His bundle recording and cardiac refractory periods were determined by the extra stimulus method. The assessment of sino atrial function was performed by measuring sinus node recovery times and sino atrial conduction times. The electrophysiological data was recorded before and 10 minutes after a slow intravenous injection of 1,5 mg/Kg of lorcainide followed by a continuous infusion at 0,02 mg/Kg/min. The following results were obtained; 1) The HV interval increased in all cases (average : II ms) 2) The QRS and QT intervals were significantly prolonged 3) Lorcainide produced a slowing of conduction and an increase in the refractory periods at atrial level 4) AV nodal conduction was unaffected 5) The sinus rate slightly increased. There were no significant changes in sinus node recovery time or sino atrial conduction. It must be concluded that, in man, lorcainide produces electrophysiological effects of antiarrhythmic agents of the quinidine type.
对15例患者研究了劳卡尼(R 15 899)的电生理效应。通过希氏束记录分析房室传导,并用额外刺激法测定心脏不应期。通过测量窦房结恢复时间和窦房传导时间来评估窦房功能。在缓慢静脉注射1.5mg/kg劳卡尼,随后以0.02mg/kg/min持续输注之前和之后10分钟记录电生理数据。获得以下结果:1)所有病例的HV间期均增加(平均:11ms);2)QRS和QT间期显著延长;3)劳卡尼使心房水平的传导减慢和不应期延长;4)房室结传导未受影响;5)窦性心率略有增加。窦房结恢复时间或窦房传导无显著变化。必须得出结论,在人体中,劳卡尼产生奎尼丁类型抗心律失常药物的电生理效应。